Skip to main content

Superstring Capital Management LP

SEC CIK
0001931118
Latest filing
Aug 14, 2026

MLTX holding history

MoonLake Immunotherapeutics in every 13F filed by Superstring Capital Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q1 2025
Holdings of MLTX by Superstring Capital Management LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−17,623−100.0%Sold outHolders
Q2 202517,623$831.8K1.0%−14,522−45.2%ReducedHolders
Q1 202532,145$1.26M1.5%+32,145NewHolders